There’s a need for additional #ColorectalCancer treatment options. When diagnosed in the metastatic phase, median overall survival is approximately one year. Hear how our scientists are working to develop medicines to help improve outcomes for patients: https://bit.ly/3Y34WYJ #ColorectalCancerAwarenessMonth [Video description: A person shares their experience with colorectal cancer and an AbbVie scientific leader shares how we’re working to address patients’ needs.]
About us
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- Website
-
http://www.abbvie.com
External link for AbbVie
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- North Chicago, Illinois
- Type
- Public Company
- Specialties
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care
Locations
Employees at AbbVie
Updates
-
Fostering an inclusive environment where everyone feels empowered to thrive is core to our values. In recognition of #NeurodiversityCelebrationWeek, hear the perspectives of some of our Ability employee resource group members on the significance of supportive language. #BelongAtAbbVie #ThisIsND [Video description: AbbVie employees share how they feel specific language around neurodiversity has helped create a more positive, inclusive environment for the neurodiverse community.]
-
Through our R&D efforts in precision medicine, we are striving to help address unmet patient needs in colorectal cancer. This Colorectal Cancer Awareness Month, hear from the CEO of the Colorectal Cancer Alliance, Michael Sapienza, as he shares his perspectives. #oncology #colorectalcancer #colorectalcancerawareness Learn more about our oncology research focus areas: https://bit.ly/4hk124F [Video Description: On-screen text reads, “Despite remarkable progress in recent years, significant unmet needs persist in colorectal cancer care. With young-onset diagnoses on the rise, it is more critical than ever to propel cutting-edge research forward through initiatives like Project Cure CRC, driving the development of innovative therapies that improve patient outcomes and transform the future of care. – Michael Sapienza, CEO Colorectal Cancer Alliance”
-
Your journey to making an impact begins here. Explore opportunities to collaborate with passionate innovators – see our open roles: https://bit.ly/4bDllcc #careers #jobs
-
-
See how personal connections and a wide range of #healthcare experience drives Brittany Winstead, PharmD, RPh’s work with our #oncology R&D team. Watch the full conversation: https://bit.ly/3FqxJ2W [Video description: Two AbbVie employees sitting at a table building a microscope and a bridge while discussing one employee's work and what drives her.]
-
#ColorectalCancer (CRC) is a serious disease and the third most common cancer worldwide. Learn how we’re working to advance #SolidTumor research to help address the unmet needs for people with CRC: https://bit.ly/4hu4zNL #ColorectalCancerAwarenessMonth [Video description: A person shares their experience with colorectal cancer and an AbbVie scientific leader shares how we’re working to address patients’ needs.]
-
Discovering and delivering innovative medicines and solutions starts with collaboration. That’s why AbbVie Partnering Days bring together researchers, #entrepreneurs and #biotechs worldwide to connect with our senior R&D and business development teams, explore our external innovation priorities and build partnerships that drive scientific progress. This year, we’re hosting Partnering Days in cities around the world, including Tokyo, Shanghai, Brussels and Stockholm. Learn more: https://bit.ly/41Kokux
-
-
Discover innovation and collaboration at our Canada office, where our vibrant multicultural environment fosters community and fuels our mission to improve lives globally. Explore our #career opportunities and join us: https://bit.ly/4bHEPvW #AbbVieLife [Video description: An AbbVie employee in our Canada office shares details about the workspace, areas for team collaboration and more.]
-
Breakthroughs don’t just happen in the lab – they happen in your #career, too. We offer our employees opportunities and support to transform their potential into reality through programs like Learn.Develop.Perform. Discover our approach to learning and #development: https://bit.ly/3QZ0EO4 #AbbVieLife [Video description: Footage showing AbbVie employees utilizing the Learn.Develop.Perform. program in various settings, along with footage from the lab and in the office, ending with employees stating, “LDP is me.”]
-
NEWS: Andy Anisfeld and Chudi Nduaka highlight our presence at #AAD2025 and reiterate our commitment to redefining treatment expectations for people living with chronic inflammatory skin conditions. [Image description: Andrew Anisfeld, Ph,D., VP, Global Medical Affairs, Immunology, says, “AbbVie's presence at AAD this year highlights our commitment to elevating dermatological care through innovative treatment solutions.” Chudi Nduaka, Therapeutic Head, Dermatology Medical Affairs, says, “We look forward to continuing our work in improving outcomes for patients living with chronic inflammatory skin conditions.”]
Affiliated pages
Similar pages
Browse jobs
Stock
ABBV
NYSE
20 minutes delay
$211.39
-0.575 (-0.271%)
- Open
- 212.17
- Low
- 210.8
- High
- 212.88
Data from Refinitiv
See more info on